Considerations When Initiating Psoriasis Patients on Biologic Therapy

被引：0

作者：

Zeichner, Joshua A. ^{[1
]}

机构：

[1] Mt Sinai Med Ctr, New York, NY 10029 USA

来源：

JOURNAL OF DRUGS IN DERMATOLOGY | 2012年 / 11卷 / 05期

关键词：

C VIRUS-INFECTION; RHEUMATOID-ARTHRITIS; CONTROLLED-TRIAL; DOUBLE-BLIND; MONOCLONAL-ANTIBODY; NATIONAL PSORIASIS; ETANERCEPT; VACCINATIONS; TUBERCULOSIS; USTEKINUMAB;

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Several types of systemic therapies exist to treat psoriasis. These include traditional immunosuppressive agents such as cyclosporine and methotrexate. Oral retinoids such as acitretin may also be appropriate in some patients. The scope of this paper, however, will focus on the use of targeted immunologic therapies, know as biologic agents.

引用

页码：S11 / S14

页数：4

共 50 条

[1] Treatment patterns and therapy effectiveness in psoriasis patients initiating biologic therapy in England
Khalid, Javaria Mona
Fox, Kathleen M.
Globe, Gary
Maguire, Andrew
Chau, Dina
[J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2014, 25 (01) : 67 - 72
[2] When should systemic biologic therapy for psoriasis be discontinued?
Dao, Diem-Phuong D.
Pixley, Jessica N.
Feldman, Steven R.
[J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
[3] Biologic therapy of psoriasis in haemodialysed patients
Urbancek, S.
Pecova, T.
Vorcakova, K.
Martinaskova, K.
Bielikova, M.
[J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 75 - 75
[4] Teledermatological Monitoring of Psoriasis Patients on Biologic Therapy
Koller, Silvia
Hofmann-Wellenhof, Rainer
Hayn, Dieter
Weger, Wolfgang
Kastner, Peter
Schreier, Guenter
Salmhofer, Wolfgang
[J]. ACTA DERMATO-VENEREOLOGICA, 2011, 91 (06) : 680 - 685
[5] Persistence of biologic therapy in psoriasis patients with comorbidity
Jacobi, Arnd
Rustenbach, Stephan J.
Augustin, Matthias
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB262 - AB262
[6] COST-EFFECTIVENESS OF SECUKINUMAB AS FIRST BIOLOGIC TREATMENT FOR PSORIASIS COMPARED WITH INITIATING OTHER BIOLOGIC THERAPY IN GERMANY
Augustin, M.
Krieger, T.
McBride, D.
Graham, C. N.
Melzer, N.
Kneidl, J.
Neidhardt, K.
[J]. VALUE IN HEALTH, 2016, 19 (07) : A568 - A569
[7] SWITCH PATTERNS AND TOTAL COSTS IN BIOLOGIC-NAIVE PATIENTS INITIATING APREMILAST OR A BIOLOGIC FOR THE TREATMENT OF PSORIASIS
Wu, J.
Pelletier, C.
Ung, B.
Tian, M.
Ni, Q.
Curtis, J. R.
[J]. VALUE IN HEALTH, 2018, 21 : S426 - S426
[8] Biologic therapy for psoriasis
Ozbilir, Ozlem
Gulekon, Ayla
[J]. TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2005, 39 (04): : 233 - 240
[9] BIOLOGIC THERAPY AND PSORIASIS
Gamo, Reyes
Lopez-Estebaranz, Jose L.
[J]. ACTAS DERMO-SIFILIOGRAFICAS, 2006, 97 (01): : 1 - 17
[10] A Retrospective Review of Patients' Response to Biologic Therapy for Psoriasis
Bagel, Jerry
Butler, Brianna
Nelson, Elise
Hetzel, Alexa
[J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2021, 20 (04) : 442 - 449

← 1 2 3 4 5 →